Overview

Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir

Status:
Completed
Trial end date:
2019-09-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) and safety of a 90-day intravaginal ring (IVR) containing tenofovir (TFV).
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Tenofovir